Uwe Schwindel

458 total citations
4 papers, 345 citations indexed

About

Uwe Schwindel is a scholar working on Genetics, Hematology and Rheumatology. According to data from OpenAlex, Uwe Schwindel has authored 4 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Hematology and 2 papers in Rheumatology. Recurrent topics in Uwe Schwindel's work include Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Eosinophilic Disorders and Syndromes (2 papers). Uwe Schwindel is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Eosinophilic Disorders and Syndromes (2 papers). Uwe Schwindel collaborates with scholars based in Germany, Switzerland and Italy. Uwe Schwindel's co-authors include Rüdiger Hehlmann, Andreas Hochhaus, Martin C. Müller, Sebastian Kreil, Peter Paschka, Kirsten Merx, Claudia Schoch, Tanja Lahaye, Ute Berger and Martin Müller and has published in prestigious journals such as Cancer, Leukemia and Haematologica.

In The Last Decade

Uwe Schwindel

4 papers receiving 338 citations

Peers

Uwe Schwindel
Lucy C. Crossman United States
Jodi Braley Australia
Nataliia Glushko Ukraine
Fabian Lang Germany
Adam R. Craig United States
Mindaugas Jurgutis United Kingdom
Rafal Falinski United States
Luana Bavaro Italy
Katy Knight United Kingdom
Lauren T. Adrian United States
Lucy C. Crossman United States
Uwe Schwindel
Citations per year, relative to Uwe Schwindel Uwe Schwindel (= 1×) peers Lucy C. Crossman

Countries citing papers authored by Uwe Schwindel

Since Specialization
Citations

This map shows the geographic impact of Uwe Schwindel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Schwindel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Schwindel more than expected).

Fields of papers citing papers by Uwe Schwindel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Schwindel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Schwindel. The network helps show where Uwe Schwindel may publish in the future.

Co-authorship network of co-authors of Uwe Schwindel

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Schwindel. A scholar is included among the top collaborators of Uwe Schwindel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Schwindel. Uwe Schwindel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Hanfstein, Benjamin, Martin C. Müller, Sebastian Kreil, et al.. (2010). Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy. Haematologica. 96(3). 360–366. 36 indexed citations
2.
Müller, Martin, Giuseppe Saglio, Feng Lin, et al.. (2007). An international study to standardize the detection and quantitation of BCR-ABL transcripts from stabilized peripheral blood preparations by quantitative RT-PCR. Haematologica. 92(7). 970–973. 33 indexed citations
3.
Frank, Oliver, Benedikt Brors, Alice Fabarius, et al.. (2006). Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. Leukemia. 20(8). 1400–1407. 85 indexed citations
4.
Lahaye, Tanja, Ute Berger, Peter Paschka, et al.. (2005). Response and resistance in 300 patients with BCR‐ABL–positive leukemias treated with imatinib in a single center. Cancer. 103(8). 1659–1669. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucy C. Crossman Breakdown of academic impact, for papers by Jodi Braley Breakdown of academic impact, for papers by Nataliia Glushko Breakdown of academic impact, for papers by Fabian Lang Breakdown of academic impact, for papers by Adam R. Craig Breakdown of academic impact, for papers by Mindaugas Jurgutis Breakdown of academic impact, for papers by Rafal Falinski Breakdown of academic impact, for papers by Luana Bavaro Breakdown of academic impact, for papers by Katy Knight Breakdown of academic impact, for papers by Lauren T. Adrian
Rankless by CCL
2026